	Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study. Hemasphere Polverelli N, Chiappella A, Carniti C, Zinzani P, Musso M, Tisi MC, Ciceri F, Cutini I, Santoro A, Chiusolo P, Barbui AM, Farina M, Donzelli L, Brunello L, Martino M, Krampera M, Castellino A, Grillo G, Botto B, Olivieri J, Clerico M, Musto P, Olivieri A, Bianchessi A, Defrancesco I, Losi G, Zerbi C, Martini G, Roncoroni E, Gotti M, Benevento MG, Taurino A, Fedina A, Corradini P, Arcaini L. PMID: 42256547 [PubMed]
	Hepatitis D in the Middle East: A Review of Disease Burden, Health-System Barriers, and Strategic Directions for Management and Elimination. Cureus Alkhatry M, Alwan AJ, Qutub A, Alzanbagi A, Alzaabi F, Al Quraishi H, Al Mattooq M, Taha M, Altarrah MY, Alnahdi N, Al Marzooqi SH, Nabil Y, Aba-Alkhail F. PMID: 42255803 [PubMed]
	Response to "Comment on 'Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray'". Hepatol Res Wada J, Abe K, Ohira H. PMID: 42252793 [PubMed - as supplied by publisher]
	Autoimmune Hepatitis in Transition: Advances in Diagnosis, Management, and Future Perspectives. Kurume Med J Arinaga-Hino T, Kawaguchi T. PMID: 42252183 [PubMed - as supplied by publisher]
	Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives. Antiviral Res Shue TM, Cataneo AHD, Athanasiadis A, Jones CE, de Jong YP, Shlomai A, Michailidis E. PMID: 42252000 [PubMed - as supplied by publisher]
	Seroprevalence of Hepatitis B and C Viral Infections Among Patients With Diabetes Mellitus in Africa: A Systematic Review and Meta-Analysis. J Int Assoc Provid AIDS Care Abebe AD, Tassew WC, Zeleke AM, Ferede YA, Beyene JA. PMID: 42249266 [PubMed - in process]
	Universal hepatitis B birth-dose: an evidence-based standard. Infect Dis (Lond) Rath S. PMID: 42248814 [PubMed - as supplied by publisher]
	Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters. Tunis Med Ben Mohamed A, Chtioui S, Yakoubi M, Gharbi G, Ghachem I, Mahmoudi M, Khsiba A, Medhioub M, Hamzaoui ML. PMID: 42246718 [PubMed - in process]
	Ahead, a Novel Validated Machine Learning Model for Clinical Diagnosis of Alcohol Associated Hepatitis. Res Sq Malicote D, Im G, Weinberg E, Kwong A, Shasthry SM, Rastogi A, Tondon R, Verma N, Valsan A, Kwo P, Reddy R, Sarin S, Dunn W, Singal AK. PMID: 42245799 [PubMed]
	Traveling with chronic viral hepatitis. Trop Dis Travel Med Vaccines Celik D, Silva CN, Santos L, Habibovic S, Corovic IF, Duduveche AE, Cinar G, Kucukkaya S, Khopkar-Kale P, Rawat SK, Gherlan GS, Rajan AK, Zerja A, Miron VD, ESCMID Study Group for Viral Hepatitis (ESGVH). PMID: 42243975 [PubMed]
	Comparative evaluation of Hepassocin, DCP, and AFP-L3 for non-invasive assessment of liver fibrosis in Hepatitis B infection. BMC Infect Dis Nair DM, Vajravelu LK, Paneerselvam V, Lathakumari RH, Vimala PB, Thulukanam J. PMID: 42243745 [PubMed - as supplied by publisher]
	Comprehensive multi-omics analysis identifies cancer subtypes and prognostic signatures of hepatitis B virus-associated hepatocellular carcinoma. NPJ Precis Oncol Wang R, Ren B, Zhang X, Liu B, Zhou W. PMID: 42243437 [PubMed - as supplied by publisher]
	RECOMPENSATION FOLLOWING ALCOHOL-RELATED HEPATITIS IS ASSOCIATED WITH INCREASED SURVIVAL: RESULTS FROM A MULTICENTER STUDY. Clin Gastroenterol Hepatol Gratacós-Ginès J, Ruz-Zafra P, Herms Q, Celada-Sendino M, Villagrasa A, Cáceres F, Martín-Mateos R, Echavarría V, Sánchez J, García S, Barreales M, Tejedor-Tejada J, Vázquez-Rodríguez S, Cañete N, Fernández-Carrillo C, Valenzuela M, Marti-Aguado D, Horta D, Quiñones M, Bernal-Monterde V, Acosta S, Artaza T, Pinazo J, Villar-Lucas C, De la Torre MP, Clemente-Sánchez A, Badia-Aranda E, Alventosa-Mateu C, Giráldez-Gallego Á, Rivera-Esteban J, Solís-Muñoz P, Alvarado-Tapias E, Cabezas J, Ventura-Cots M, Fernández-Rodríguez C, Rodríguez M, Aguilera V, Tomé S, Caballería J, Bataller R, Pose E, REHALC Registry investigators. PMID: 42242660 [PubMed - as supplied by publisher]
	Lonafarnib for chronic hepatitis delta: Clinical mechanism of action, development, and evolving role in combination therapy. Antiviral Res Haddadin R, Aboujamra D, Glenn JS, Kawas L, Taylor R, Hua X, Asselah T, Gish RG. PMID: 42242630 [PubMed - as supplied by publisher]
	Hepatitis B Screening, Antiviral Prophylaxis, and Reactivation Risk in Rituximab-Treated Patients: A 17-Year Population-Based Cohort Study Highlighting Current Practices and Gaps. Dig Dis Sci Baker FA, Tatour M, Yehya A, Saadi T, Hazzan R. PMID: 42240959 [PubMed - as supplied by publisher]
	Informing the Equitable Implementation of Hepatitis C Interventions: Cost-Effectiveness Modeling in Rural Populations of People Who Inject Drugs. Pharmacoeconomics Tubach SA, Castonguay FM. PMID: 42240812 [PubMed - as supplied by publisher]
	Seroprevalence of Hepatitis B and Hepatitis C in Patients Hospitalized in Palliative Care Service. Saudi Med J Koçak MB, Güler B. PMID: 42238206 [PubMed - indexed for MEDLINE]
	Viral Hepatitis. Vet Clin North Am Equine Pract Tomlinson J. PMID: 42236337 [PubMed - as supplied by publisher]
	Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. Front Immunol Zhu C, Yang J, Sheng Y, Fang M. PMID: 42233029 [PubMed - indexed for MEDLINE]
	Municipal waste workers and hepatitis B and C virus and HTLV infection a cross-sectional study. Virus Genes Rafiei-Abatari F, Mohtasham-Amiri Z, Pourgholaminejad A, Jafari-Shakib R. PMID: 42230468 [PubMed - as supplied by publisher]

Articles 1 - 20 / 88274

Page 1 of 4414



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy